Study questions worth of ultrasound and removing benign ovarian cysts in preventing cancer
This article was originally published in Clinica
Executive Summary
A 15-year study of over 5,000 women in the UK has shown for the first time that removing benign ovarian cysts does not reduce a woman's chance of dying from ovarian cancer. The study has also questioned the value of ultrasound as a cost-effective screening tool for the disease.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.